EFFICACY OF DUPILUMAB IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA AND WITH HIGH SLEEP DISTURBANCE: A POST HOC ANALYSIS FROM LIBERTY ASTHMA QUEST

被引：0
|
作者：
Maspero, J. [1 ]
Shafazand, S. [2 ]
Cole, J. [3 ]
Pavord, I. D. [4 ]
Busse, W. W. [5 ]
Msihid, J. [6 ]
Gall, R. [7 ]
Soler, X. [7 ]
Siddiqui, S. [7 ]
Khan, A. H. [6 ]
Gomez, L. D. P. [8 ]
Jacob-Nara, J. A. [9 ]
机构：
[1] Fdn CIDEA, Buenos Aires, DF, Argentina
[2] Miller Sch Med, Miami, FL USA
[3] OK Clin Res, Edmond, OK USA
[4] Univ Oxford, NIHR Oxford Biomed Res Ctr, Oxford, England
[5] Univ Wisconsin, UW Allergy Pulm & Crit Care Med, Madison, WI USA
[6] Sanofi, Chilly Mazarin, France
[7] Regeneron, Tarrytown, NY USA
[8] Sanofi, Reading, Berks, England
[9] Sanofi, Bridgewater, NJ USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCR53
引用
收藏
页码：S550 / S550
页数：1
相关论文
共 50 条
  • [11] Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
    Castro, M.
    Corren, J.
    Pavord, I. D.
    Maspero, J.
    Wenzel, S.
    Rabe, K. F.
    Busse, W. W.
    Ford, L.
    Sher, L.
    FitzGerald, J. M.
    Katelaris, C.
    Tohda, Y.
    Zhang, B.
    Staudinger, H.
    Pirozzi, G.
    Amin, N.
    Ruddy, M.
    Akinlade, B.
    Khan, A.
    Chao, J.
    Martincova, R.
    Graham, N. M. H.
    Hamilton, J. D.
    Swanson, B. N.
    Stahl, N.
    Yancopoulos, G. D.
    Teper, A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (26): : 2486 - 2496
  • [12] Type 2 Biomarkers Associated with Dupilumab Efficacy in Patients with Uncontrolled, Moderate-To-Severe Asthma Enrolled in the Phase 3 Study LIBERTY ASTHMA QUEST
    Wenzel, S. E.
    Pavord, I.
    Zhang, B.
    Maroni, J.
    Rowe, P.
    Hamilton, J. D.
    Swanson, B. N.
    Amin, N.
    Pirozzi, G.
    Graham, N. M.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [13] Dupilumab Produces Rapid and Sustained Improvements in Asthma-Related Symptoms in Patients with Uncontrolled, Moderate-To-Severe Asthma from the LIBERTY ASTHMA QUEST Study
    Corren, J.
    Castro, M.
    Guillonneau, S.
    Chao, J.
    Amin, N.
    Pirozzi, G.
    Graham, N. M.
    Teper, A.
    Khan, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [14] Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with fungal sensitization
    Corren, Jonathan
    Hanania, Nicola A.
    Busse, William W.
    Sher, Lawrence D.
    Altincatal, Arman
    Hardin, Megan
    Mannent, Leda P.
    Amin, Nikhil
    Lederer, David J.
    Soler, Xavier
    Jacob-Nara, Juby A.
    Rowe, Paul J.
    Deniz, Yamo
    CLINICAL AND EXPERIMENTAL ALLERGY, 2023, 53 (10): : 1020 - 1030
  • [15] DUPILUMAB REDUCES SEVERE EXACERBATION RATE AND IMPROVES LUNG FUNCTION IN ADOLESCENT PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA: FROM THE LIBERTY ASTHMA QUEST STUDY
    Maspero, Jorge
    Fitzgerald, Mark
    Pavord, Ian
    Wenzel, Sally
    Zhang, Bingzhi
    Maroni, Jaman
    Rowe, Paul
    Amin, Nikhil
    Pirozzi, Gianluca
    Ruddy, Marcella
    Akinlade, Bolanle
    Graham, Neil
    Teper, Ariel
    CHEST, 2018, 154 (04) : 25A - 27A
  • [16] Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis
    Busse, William W.
    Wenzel, Sally E.
    Casale, Thomas B.
    FitzGerald, J. Mark
    Rice, Megan S.
    Daizadeh, Nadia
    Deniz, Yamo
    Patel, Naimish
    Harel, Sivan
    Rowe, Paul J.
    Graham, Neil M. H.
    O'Riordan, Thomas
    Pavord, Ian D.
    LANCET RESPIRATORY MEDICINE, 2021, 9 (10): : 1165 - 1173
  • [17] Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma recruited from Japanese centers in the phase 3 LIBERTY ASTHMA TRAVERSE study
    Tohda, Yuji
    Nakamura, Yoichi
    Fujisawa, Takao
    Ebisawa, Motohiro
    Msihid, Jerome
    Djandji, Michel
    Ortiz, Benjamin
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    Ishida, Masato
    Arima, Kazuhiko
    ALLERGOLOGY INTERNATIONAL, 2023, 72 (01) : 89 - 99
  • [18] Impact of Exacerbation History on Dupilumab Efficacy in Children with Uncontrolled Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE Study
    Guilbert, Theresa W.
    Tolcachier, Alberto
    Fiocchi, Alessandro G.
    Katelaris, Constance H.
    Phipatanakul, Wanda
    Begin, Philippe
    de Mir, Ines
    Altincatal, Arman
    Gall, Rebecca
    Ledanois, Olivier
    Radwan, Amr
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    JOURNAL OF ASTHMA AND ALLERGY, 2024, 17 : 143 - 159
  • [19] Dupilumab Improved Lung Function in Patients with Uncontrolled, Moderate-to-Severe Asthma Despite Exacerbation Events During the LIBERTY ASTHMA QUEST Study
    Rabe, K. F.
    Castro, M.
    Wenzel, S. E.
    Corren, J.
    Pavord, I. D.
    Katelaris, C.
    Tohda, Y.
    Rice, M. S.
    Lu, Y.
    Rowe, P.
    Staudinger, H. W.
    Amin, N.
    Akinlade, B.
    Graham, N. M. H.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [20] Efficacy of Dupilumab in Pediatric Patients with Uncontrolled, Moderate-to-Severe Asthma With and Without Ongoing Atopic Comorbid Disease: LIBERTY ASTHMA VOYAGE
    Guilbert, T. W.
    Deschildre, A.
    Jackson, D. J.
    Begin, P.
    Zeiger, R. S.
    Szefler, S. J.
    Altincatal, A.
    Gall, R.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y.
    Djandji, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
12345